Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001903596-24-000686
Filing Date
2024-11-21
Accepted
2024-11-21 14:51:32
Documents
15
Period of Report
2024-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ammj_8k.htm   iXBRL 8-K/A 24690
2 BINDING LETTER OF INTENT ex10_1.htm EX-10.1 27693
3 CONTENTS ex10_2.htm EX-10.2 56669
  Complete submission text file 0001903596-24-000686.txt   294305

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acc-20241108.xsd EX-101.SCH 3066
5 XBRL LABEL FILE acc-20241108_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE acc-20241108_pre.xml EX-101.PRE 22394
18 EXTRACTED XBRL INSTANCE DOCUMENT ammj_8k_htm.xml XML 3415
Mailing Address 200 UNION ST. SUITE 200 LAKEWOOD CO 80228
Business Address 200 UNION ST. SUITE 200 LAKEWOOD CO 80228 303-974-4770
American Cannabis Company, Inc. (Filer) CIK: 0000945617 (see all company filings)

EIN.: 901116625 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-26108 | Film No.: 241483791
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)